Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Toxys Opens NY Sales Office and Facility in Maryland | Contract Pharma
Breaking News

Toxys Opens NY Sales Office and Facility in Maryland

Expansion in the U.S. supports the company’s growth strategy.

Toxys BV, a Dutch biotech company that offers a broad spectrum of in vitro toxicology solutions for the safety assessment of novel medicines, (agro)chemicals, cosmetics and food ingredients, has opened a sales office in New York (NY) and a production facility in Gaithersburg (MD) to accelerate its growth.
 
With these new facilities, Toxys will be able to better serve its clients in North America and make the Toxys assays readily available.
 
The opening of an office and production facility in the U.S. supports the company’s growth strategy to become a global leading supplier of expert mechanistic in vitro chemical safety assays. These assays provide animal-free safety testing of novel medicines, chemicals, and consumer products. Toxys is an expert in the fields of genotoxicity, developmental toxicology, and mechanistic toxicity testing and has developed the ToxTracker, ReproTracker and ToxProfiler assays.
 
“The decision to expand our presence into the United States was a logical step in our business growth strategy,” said Giel Hendriks, president. “We have made important progress on development of innovative animal-free tests for drug and chemical safety testing. With our new US facilities, we are ready to further expand our business globally and continue to work on the development of novel solutions for toxicological research.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters